{"id":"W4417002349","doi":"10.1182/blood-2025-5820","title":"Functional high-risk Relapsed/Refractory multiple myeloma (RRMM) outcomes with belantamab mafodotin (belamaf): Dreamm-7 and dreamm-8 subgroup analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Subgroup analysis; Clinical endpoint; Hazard ratio; Dexamethasone; Adverse effect; Multiple myeloma; Clinical trial; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004103901,0.001185219,0.003878085,0.001079544,0.0002546153,0.001100373,0.0008006888,0.0008324165,0.00245456],"category_scores_gemma":[0.004635078,0.0003026224,0.01123137,0.001005167,0.0002955826,0.0006289039,0.0008853851,0.001121412,0.0002144107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007500688,"about_ca_system_score_gemma":0.0008249297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001157304,"about_ca_topic_score_gemma":0.003199256,"domain_scores_codex":[0.9970562,0.001254919,0.0006149894,0.000502625,0.0003205157,0.0002506362],"domain_scores_gemma":[0.9982374,0.0008331045,0.0004273159,0.0002042174,0.0001299569,0.0001680439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4661095,0.0007611379,0.1511674,0.01180166,0.2781984,0.0005521344,0.0003281199,0.003837404,0.005914972,0.0006419391,0.008563372,0.0721241],"study_design_scores_gemma":[0.121084,0.02899038,0.3931749,0.002008269,0.419053,0.001371918,0.0007308589,0.009472576,0.003556479,0.005460041,0.0147841,0.0003135735],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9221261,0.05966789,0.002220888,0.001112073,0.0003488068,0.001931343,0.009917807,0.00009397718,0.002581103],"genre_scores_gemma":[0.9908531,0.002435747,0.0007906951,0.0003870222,0.0001664397,0.001405903,0.003406733,0.00002365166,0.0005307071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004103901,"threshold_uncertainty_score":0.02170378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00996949051566891,"score_gpt":0.2462573102883356,"score_spread":0.2362878197726667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}